Features | Partner Sites | Information | LinkXpress
Sign In
PURITAN MEDICAL
GLOBETECH PUBLISHING LLC
GLOBETECH PUBLISHING LLC

Novel Filtration System Removes Proteins and Phospholipids from Analytical Samples

By BiotechDaily International staff writers
Posted on 03 Feb 2014
Image: The ISOLUTE PLD+ protein and phospholipid removal plate (Photo courtesy of Biotage).
Image: The ISOLUTE PLD+ protein and phospholipid removal plate (Photo courtesy of Biotage).
Biotechnology and other life science researchers now have available a novel filter system that removes both proteins and phospholipids, which leaves samples ready for LC-MS/MS (liquid chromatography-mass spectroscopy) analysis.

The Biotage (Uppsala, Sweden) ISOLUTE PLD+ plate combines protein and phospholipid removal from blood-based matrix samples and provides simple and effective cleanup for LC-MS/MS analysis. According to the manufacturer, ISOLUTE PLD+ plates remove more than 99% of plasma proteins and phospholipids, the main causes of ion suppression, leading to cleaner extracts and increased sensitivity, signal-to-noise, for a broad range of analytes.

ISOLUTE PLD+ plates are available in standard 96-well format and can handle sample volumes of 100 to 200 microliters. Operation of the ISOLUTE PLD+ plate includes a filtration step that can be accomplished with a 96-well compatible positive pressure manifold (such as the Biotage Pressure+ 96), a vacuum manifold (for example the Biotage VacMaster 96) and most automated liquid handling systems.

“Requiring next to no method development, ISOLUTE PLD+ can be integrated quickly and easily into routine workflow, increasing productivity and reducing instrument downtime,” said Paul Roberts, analytical product manager at Biotage.

Related Links:

Biotage



Channels

Genomics/Proteomics

view channel
Image: Photomicrograph showing acute myeloid leukemia (AML) cells (Photo courtesy of the University of California, San Diego).

Cell Surface Protein Deletion Blocks AML Growth in Mouse Model

Cancer researchers have found that the cell surface protein tetraspanin3 (Tspan3) is required for the development and propagation of the fast-growing and extremely difficult-to-treat blood cancer, acute... Read more

Drug Discovery

view channel
Image: A new micelle delivery system for the protective polyphenols resveratrol and quercetin (mRQ) may have value in cancer chemotherapy (Photo courtesy of Oregon State University).

Micelles Containing Resveratrol and Quercetin Reverse Doxorubicin Cardiotoxicity

Cancer researchers blocked the toxic effects of the cancer drug doxorubicin (DOX) by administering it together with the plant antioxidants resveratrol and quercetin. Although in use for more than 40... Read more

Business

view channel

Teva Buys Allergan Generic Business Unit

Teva Pharmaceutical Industries (Petah Tikva, Israel) has bought the Allergan (Irvine, CA, USA) generic drugs business for USD 40.5 billion in cash and stock, solidifying its position as the world's largest generic drug maker. Under the terms of the agreement, Teva will pay USD 33.75 billion in cash and USD 6.... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.